secwatch / observer
8-K filed May 7, 2026, 7:59 PM ET ticker CCLD CIK 0001582982
earnings confidence high sentiment positive materiality 0.70

CareCloud Q1 revenue $31.3M (+13% YoY), reaffirms 2026 guidance; Series B redemption set for May 15

CareCloud, Inc.

2026-Q1 EPS reported -$0.01 revenue$31,270,000

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

CareCloud, Inc. reported the quarter ended March 31, 2026 results: revenue $31.3 million, net income $922,000, EPS ($0.01). Guidance reaffirmed.

Period
the quarter ended March 31, 2026
Revenue
$31.3 million
Net income
$922,000
EPS
($0.01)
Guidance
reaffirmed
Result
reported results
Exact text from the filing
CareCloud, Inc. (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leader in AI-powered healthcare technology and revenue cycle management solutions for medical practices and health systems nationwide, today announced financial results for the quarter ended March 31, 2026. The Company reaffirmed its previously issued financial guidance following the successful closing of a $50 million credit facility, the announced redemption of 100% of its Series B Preferred Stock, and AI product launches. Together, these milestones mark a pivotal step in CareCloud’s ongoing growth trajectory—positioning the Company to scale its AI-driven revenue and expand margins, reporting its eighth consecutive quarter of positive GAAP net income with a meaningfully simpler capital structure for the future. First Quarter 2026 Financial Highlights: ● Revenue of $31.3 million, compared to $27.6 million in Q1 2025 ● GAAP net income of $922,000, compared to a net income of $1.9 million in Q1 2025 ● Adjusted EBITD
View on SEC.gov

Browse all earnings releases →

CareCloud, Inc. filing history →

Source: SEC EDGAR
accession 0001493152-26-021603
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.